Log in to save to my catalogue

Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease

Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2339630503

Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease

About this item

Full title

Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease

Publisher

London: Future Medicine Ltd

Journal title

Neurodegenerative disease management, 2019-12, Vol.9 (6), p.289-299

Language

English

Formats

Publication information

Publisher

London: Future Medicine Ltd

More information

Scope and Contents

Contents

Amyloidosis is a group of diseases characterized by extracellular deposition of amyloid fibril complexes. Fibril deposition results in organ dysfunction and possible failure. Amyloidosis is regarded as a rare disease, but in general is underdiagnosed. The two main types of systemic amyloidosis are immunoglobulin light chain and transthyretin amyloi...

Alternative Titles

Full title

Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2339630503

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2339630503

Other Identifiers

ISSN

1758-2024

E-ISSN

1758-2032

DOI

10.2217/nmt-2019-0020

How to access this item